Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NovoCure Ltd
Report date December 20, 2019 · Filed December 26, 2019
Section 16 reporting ended · disclosed 2019-12-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 8,954,748 |
Reported balance
After 2019-12-20 transaction · row 1
1 source rowRow 1 · 2019-12-20 · Gift · Disposed 1,000,000 · Balance 8,954,748 |
| Ordinary SharesSEC Table I · non-derivative | IndirectThe Hansjoerg Wyss 2004 Descendants Trust | 825,649 |
Reported balance
Holding disclosure · report date 2019-12-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 825,649 F1: Mr. Wyss possesses no voting or investment power over shares held by The Hansjoerg Wyss 2004 Descendents Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Wyss possesses no voting or investment power over shares held by The Hansjoerg Wyss 2004 Descendents Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2019 Filed Dec 26, 2019 22:28 UTC | NovoCure Ltd NVCR · Entity 4494 | GiftOrdinary Shares | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001382963-19-000162 · edgar.xml · nonDerivative · entry 1 Wyss Hansjoerg · CIK 0001618488 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,954,748 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.